Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (6): 366-367.
Previous Articles Next Articles
ZHUANG Hong-yan1,2,3, XUE Chun-miao4,*, XIAO Min4, CAO Jun-ling4, MAO Liu-ying4, ZHANG Sha-sha4, LIANG Yan
Received:2018-08-03
Revised:2018-08-03
Online:2018-06-15
Published:2018-08-03
CLC Number:
ZHUANG Hong-yan, XUE Chun-miao, XIAO Min, CAO Jun-ling, MAO Liu-ying, ZHANG Sha-sha, LIANG Yan. One Case of Cushing's Syndrome Induced by Long-term Oral Dexamethasone Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(6): 366-367.
Add to citation manager EndNote|Ris|BibTeX
| [1] Bas V N, Cetinkaya S, Aycan Z.Iatrogenic Cushing Syndrome due to nasal steroid drops[J].Eur J Pediatr,2012,171(4):735-736. [2] 林庆程,林强.临床X线读片诊断要诀[M].杭州:浙江科学技术出版社,2000:230-232. [3] 沈周俊. 现代肾上腺外科诊疗学[M].上海:上海交通大学出版社,2015:75-77. [4] 张永红. 神经外科常见疾病诊治指南及专家共识[M].兰州:兰州大学出版社,2016:198. [5] Plotz C M, Knowlton A I, Ragan C.The natural history of cushing's syndrome[J].Am J Med,1952,13(5):597-614. [6] Lindholm J, Juul S, Jorgensen J O, et al.Incidence and late prognosis of cushing's syndrome: a population-based study[J]. J Clin Endocrinol Metab, 2001, 86(1): 117-123. [7] Dekkers O M, Horvath-Puho E, Jorgensen J O, et al.Multisystem morbidity and mortality in cushing's syndrome: a cohort study[J]. J Clin Endocrinol Metab, 2013, 98(6): 2277-2284. [8] 冯铭,卢琳,陆召麟,等.美国库欣综合征治疗指南(2015版)解读[J].中华医学杂志,2016,96(31):2452-2453. [9] 中华医学会内分泌学分会.库欣综合征专家共识(2011年)[J].中华内分泌代谢杂志,2012,28(2):96-102. [10] 张茂姬,罗敏.醋酸泼尼松片和注射用氢化可的松琥珀酸钠致过敏反应1例[J].中国药物警戒,2017,14(4):255-256. [11] Hopkins R L, Leinung M C.Exogenous Cushing's Syndrome and glucocorticoid with drawal[J]. Endocrinol Metab Clin North Am, 2005, 34(2):371-384. [12] 国家药典委员会.临床用药须知[M].北京:中国医药科技出版社,2010:604-605. [13] 茅伟安. 皮肤病用药速查手册[M]. 北京:金盾出版社,2014:274-275. [14] 董宗祈. 糖皮质激素与促皮质激素的关系及应用[J].中国实用儿科杂志,2000,15(1):17-18. [15] 卢琳,曾正陪.美国内分泌学会的临床指南:Cushing综合征的诊断[J].中华内分泌代谢杂志,2008,24(5):552-555. [16] 中华医学内分泌学分会,Cushing综合征专家共识(2011年)[J].中华内分泌代谢杂志,2012,28(2):96-102. [17] 丁国宪. 内分泌代谢性疾病临床处方手册[M].南京:江苏科学技术出版社,2015:112-114. [18] 张庆柱. 药物治疗学[M].济南:山东大学出版社,2016:335-337. [19] 陈莉,连加阵.地塞米松致不良反应2例[J].海军医学杂志,2007,28(3):288-289. [20] 高玉霞,王瑞霞,伦冠芬,等.长程使用糖皮质激素患者的药学监护[J].中国医院药学杂志,2013,33(10):830-836. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
